# Study of Lactobacillus in Adjuvant Treatment of RVVC

> **NCT04699240** · PHASE4 · COMPLETED · sponsor: **Peking University Shenzhen Hospital** · enrollment: 140 (actual)

## Conditions studied

- Recurrent Vulvovaginal Candidiasis

## Interventions

- **DRUG:** clotrimazole vaginal tablets
- **DRUG:** Clotrimazole vaginal tablets+ Lactobacillus

## Key facts

- **NCT ID:** NCT04699240
- **Lead sponsor:** Peking University Shenzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699240, "Study of Lactobacillus in Adjuvant Treatment of RVVC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04699240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*